Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Guillaume Baudry Added: 1 year ago
ESC HF 25 - Findings from a French nationwide cohort study investigating cardiologist follow-up show greater reduction in all-cause mortality associated with annual cardiology hospital visits.Dr Guillaume Baudry (University Hospital of Brabois, Nancy, FR) discusses findings from a nationwide trial investigating the prognostic value of heart failure stratification and cardiologist follow-up in… View more
Added: 1 month ago Source:  Radcliffe CVRM
High-sensitivity C-reactive protein (hsCRP), a marker of inflammation, has a debated role in primary cardiovascular (CV) prevention. A large, population-based study using UK Biobank data has provided further insight into its utility as a clinical biomarker for identifying individuals at residual risk who do not have known atherosclerotic cardiovascular disease (ASCVD).¹MethodologyThis population… View more
Added: 3 months ago Source:  Arrhythmia Academy
Artificial intelligence applied to electrocardiograms (ECG-AI) may offer a scalable way to identify individuals at high risk of developing heart failure (HF), potentially improving on current clinical risk estimators, according to a new pooled cohort analysis from the HeartShare/Accelerating Medicines Partnership (AMP) Heart Failure program.¹The study aimed to assess whether ECG-AI models… View more
Author(s): Michael McConnell Added: 2 months ago
ACC.26 – Dr Michael McConnell (Stanford Health Care, Stanford, CA, US) joins us to discuss findings from a prospective, multicentre clinical trial evaluating whether artificial intelligence analysis of retinal images can identify patients at elevated atherosclerotic cardiovascular risk.Findings showed strong sensitivity and specificity in identifying those at risk of ASCVD in a diverse study… View more
Author(s): Divaka Perera Added: 2 months ago
ACC 2026 — Prof Divaka Perera (Guy's & St Thomas' Hospital and King's College London, UK) joins us to discuss findings from the CHIP-BCIS3 trial, examining the role of percutaneous left ventricular unloading in patients undergoing high-risk coronary intervention.This phase 3 randomised controlled trial enrolled 300 patients with severe left ventricular dysfunction and extensive coronary artery… View more